CRIS Current Research Information System

FERRACIN, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.127
AS - Asia 7.600
EU - Europa 6.364
SA - Sud America 590
AF - Africa 436
Continente sconosciuto - Info sul continente non disponibili 61
OC - Oceania 13
Totale 23.191
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.012
CN - Cina 2.518
SG - Singapore 2.169
IT - Italia 2.114
VN - Vietnam 1.278
GB - Regno Unito 1.165
DE - Germania 792
HK - Hong Kong 595
SE - Svezia 524
BR - Brasile 406
IN - India 373
RU - Federazione Russa 344
KR - Corea 270
IE - Irlanda 237
NL - Olanda 216
FR - Francia 212
ZA - Sudafrica 132
FI - Finlandia 113
CI - Costa d'Avorio 104
EE - Estonia 104
UA - Ucraina 104
CH - Svizzera 93
AR - Argentina 92
HR - Croazia 86
SC - Seychelles 86
ID - Indonesia 82
PK - Pakistan 72
TG - Togo 64
CA - Canada 62
EU - Europa 61
AT - Austria 60
JP - Giappone 55
JO - Giordania 49
BG - Bulgaria 41
MX - Messico 41
PL - Polonia 35
EC - Ecuador 31
ES - Italia 26
BD - Bangladesh 24
IR - Iran 23
TR - Turchia 21
GR - Grecia 20
BE - Belgio 17
CL - Cile 15
AU - Australia 12
NG - Nigeria 12
PE - Perù 12
RO - Romania 12
IQ - Iraq 10
CO - Colombia 9
DK - Danimarca 9
MA - Marocco 9
UZ - Uzbekistan 9
VE - Venezuela 9
LT - Lituania 8
TH - Thailandia 8
CZ - Repubblica Ceca 7
EG - Egitto 7
UY - Uruguay 7
KE - Kenya 6
PY - Paraguay 6
TW - Taiwan 6
LB - Libano 5
DO - Repubblica Dominicana 4
MY - Malesia 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CR - Costa Rica 3
IL - Israele 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
SI - Slovenia 3
SM - San Marino 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CG - Congo 2
JM - Giamaica 2
NO - Norvegia 2
SN - Senegal 2
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CM - Camerun 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
Totale 23.175
Salva come PNG Salva come JPEG
Città #
Singapore 1.454
Fairfield 1.095
Southend 1.005
Ashburn 922
Bologna 633
Hong Kong 588
Hefei 580
Houston 493
Woodbridge 471
Seattle 457
Chandler 437
Wilmington 387
Cambridge 375
Ann Arbor 330
Ho Chi Minh City 329
Princeton 295
Beijing 277
Seoul 263
Dublin 232
Santa Clara 225
Dong Ket 217
Hanoi 214
Boardman 207
Dallas 147
Nanjing 134
Los Angeles 127
Berlin 123
Milan 120
Westminster 118
Abidjan 104
Padova 102
Frankfurt am Main 81
Rome 79
Redondo Beach 75
Helsinki 73
Bern 72
Jinan 68
Buffalo 64
Lomé 64
Shenyang 63
Jakarta 62
New York 61
San Diego 61
Saint Petersburg 59
Bengaluru 55
Shanghai 52
Tokyo 51
Hebei 50
Amman 49
Guangzhou 47
Olalla 46
Nuremberg 45
Redmond 45
Changsha 44
Tianjin 42
Sofia 41
Zhengzhou 39
London 38
Munich 37
Nanchang 36
São Paulo 36
Des Moines 34
Chicago 33
Vienna 32
Bremen 31
Reggio Emilia 31
Falls Church 30
Turin 30
Florence 29
Hangzhou 29
Falkenstein 28
Lappeenranta 28
Norwalk 28
Amsterdam 27
Da Nang 27
Warsaw 26
Toronto 25
Jacksonville 24
Jiaxing 23
Naples 23
Parma 23
Phoenix 23
Xi'an 23
Boston 22
Vicenza 22
Ferrara 20
Tongling 20
Haiphong 19
Stockholm 19
Modena 18
Palermo 18
Rio de Janeiro 18
Shenzhen 18
Taiyuan 18
Taizhou 18
Verona 18
Brooklyn 17
Düsseldorf 17
Hyderabad 17
Thái Nguyên 17
Totale 15.019
Salva come PNG Salva come JPEG
Nome #
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers 619
ARID1A in cancer: Friend or foe? 327
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 278
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 242
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 240
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells 233
Non-coding RNAs in disease: from mechanisms to therapeutics 229
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary 213
MicroRNA and Metabolic Profiling of a Primary Ovarian Neuroendocrine Carcinoma Pulmonary-Type Reveals a High Degree of Similarity with Small Cell Lung Cancer 200
Cancer of unknown primary: Challenges and progress in clinical management 200
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients 196
Basal cell carcinoma: A comprehensive review 194
Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review 193
LncRNAs as novel players in hepatocellular carcinoma recurrence 193
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients 192
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 191
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling 190
Peripheral blood cellular profile at pre-lymphodepletion is associated with {CD}19-targeted {CAR}-T cell-associated neurotoxicity 184
Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians 184
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy 180
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 180
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 180
Cancer site-specific multiple microRNA quantification by droplet digital PCR 179
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 177
Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations 177
A Systematic Review of Diagnostic and Prognostic Biomarkers for Head and Neck Cancer of Unknown Primary: An Unmet Clinical Need 176
Serum from Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 176
Association of miR-146a-5p and miR-21-5p with Prognostic Features in Melanomas 171
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 171
Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR 170
Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types 170
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 169
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 169
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 167
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 165
Absolute quantification of cell-free microRNAs in cancer patients 160
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 159
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 158
Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology 156
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 155
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 155
Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer 154
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 153
High Expression of the Sda Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer 153
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 152
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 151
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 149
Unraveling the role of microRNA/isomiR network in multiple primary melanoma pathogenesis 149
Oncogenic role of miR-483-3p at the IGF2/483 locus. 148
Estrogen Receptors and Melanoma: A Review 147
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. 146
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 146
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking 145
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 144
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC 143
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 142
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 141
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 139
Circulating non-coding RNA as biomarkers in colorectal cancer 139
Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces 138
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation 137
Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer 137
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study 134
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 134
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. 134
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 132
The Sda synthase B4GALNT2 reduces malignancy and stemness in colon cancer cell lines independently of sialyl lewis X inhibition 132
Involvement of the inconstant bursa of the fifth metatarsophalangeal joint in psoriatic arthritis: A clinical and ultrasonographic study 130
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 129
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 128
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 128
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 126
Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma 126
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 125
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 125
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 124
Altered miRNA expression in T regulatory cells in course of multiple sclerosis. 124
Quantification of circulating micrornas by droplet digital PCR 123
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 121
MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary 121
Non-coding RNA dysregulation in skin cancers 121
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma 119
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 118
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 118
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 117
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 117
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 117
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 116
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 115
Non-coding RNAs as predictive biomarkers to current treatment in metastatic colorectal cancer 115
Small extracellular vesicles deliver miR-21 and miR-217 as pro-senescence effectors to endothelial cells 115
Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients 114
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 113
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 113
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report 113
OncomiR detection in circulating body fluids: a PDMS microdevice perspective. 112
Micromarkers 2.0: An update on the role of microRNAs in cancer diagnosis and prognosis 111
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. 111
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 111
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients. 111
Totale 15.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.360 0 0 0 0 0 186 42 126 257 140 75 534
2021/20222.639 242 124 196 190 222 163 96 223 108 193 438 444
2022/20232.518 250 322 122 314 147 174 103 145 430 69 231 211
2023/20241.055 101 144 83 104 76 124 77 71 51 71 75 78
2024/20254.856 155 647 473 298 468 246 614 240 112 334 389 880
2025/20266.027 952 1.599 1.099 871 1.036 470 0 0 0 0 0 0
Totale 23.813